cerezyme
pharmacy retailing (nz) ltd t/a healthcare logistics - imiglucerase 212 u (biological product from recombinant cho cells) - powder for infusion - 40 u/ml - active: imiglucerase 212 u (biological product from recombinant cho cells) excipient: citric acid monohydrate mannitol nitrogen polysorbate 80 sodium citrate dihydrate
cerezyme 400
sanofi-aventis south africa - imiglucerase - lyophilised powder - each 10 ml liquid contains; imiglucerase 400,0 units
cerezyme 200 units
sanofi - aventis israel ltd - imiglucerase 200 u/vial - powder for solution for infusion - imiglucerase - for the long term enzyme replacement therapy for patients with a confirmed diagnosis of type 1 gaucher disease that results in one or more of the following conditions: - anemia , - thrombocytopenia , - bone disease , - hepatomegaly or splenomegaly.
cerezyme 400 u power for intravenous infusion
n/a; importer: sanofi-aventis philippines, inc.; distributor: sanofi-aventis philippines, inc. - imiglucerase - power for intravenous infusion - 400 u
cerezyme 200unit powder for solution for infusion vials
genzyme therapeutics ltd - imiglucerase - powder for solution for infusion - 200unit
cerezyme 400 u powder for concentrate for solution for infusion
genzyme europe b.v., netherlands - imiglucerase - powder for concentrate for solution for infusion - 400 u
cerezyme 400 u/vial
شركة ألفه للأدوية - ulfa pharma co. - imiglucerase 400 u/vial - 400 u/vial
cerezyme 400 u powder for concentrate for solution for infusion
genzyme europe b.v., netherlands - imiglucerase - powder for concentrate for solution for infusion - 400 u
cerezyme
genzyme australasia pty ltd - imiglucerase -
cerezyme
genzyme australasia pty ltd - imiglucerase -